Drugs.com - New Drug Approvals

US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon Hadlima (adalimumab-bwwd) Injection

INCHEON, Korea & JERSEY CITY, N.J.--(BUSINESS WIRE) May 27, 2025 -- Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has designated the Hadlima™ (adalimumab-bwwd)...

May 28, 2025 - 00:10
 0
US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon Hadlima (adalimumab-bwwd) Injection
INCHEON, Korea & JERSEY CITY, N.J.--(BUSINESS WIRE) May 27, 2025 -- Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has designated the Hadlima™ (adalimumab-bwwd)...
Read More

Tags:

Previous Article

Official: BMW M2 CS brings 523bhp for £87k

Next Article

FDA Approves Starjemza (ustekinumab-hmny), a Biosimilar to Stelara

Related Posts

FDA Approves Mezofy (aripiprazole) Oral Film for the Treatment of Schizophrenia

FDA Approves Mezofy (aripiprazole) Oral Film for the Tr...

May 12, 2025  0

FDA Grants Accelerated Approval to Avmapki Fakzynja Co-Pack (avutometinib capsules/defactinib tablets) for KRAS-Mutated Recurrent Low-Grade Serous Ovarian Cancer

FDA Grants Accelerated Approval to Avmapki Fakzynja Co-...

May 13, 2025  0

FDA Approves Imaavy (nipocalimab-aahu) for the Treatment of Generalized Myasthenia Gravis (gMG)

FDA Approves Imaavy (nipocalimab-aahu) for the Treatmen...

May 12, 2025  0